Single-Cell Technologies to Accelerate Drug Development and Cancer Treatment: Dr. Diana Stoycheva, Scailyte

X-Health.show - meet the future of healthcare

They are great soldiers.
They go after every rouge cell they can find. And kill it.
And they never forget the enemies, always ready to fight back.
We're speaking cancer treatment of the future, in clinical trials today – but not only. Single-cell analysis can serve personalized medicine, in various diseases.
You’ll hear about cell therapy to fight cancer, CAR T cell therapy, precision medicine and training cells in killing rougue cells, multiomics analysis, drug discovery powered and accelerated by AI, and coming soon: early biomarkers for endometriosis.
Dr. Diana Stoycheva is a Principal Expert Scientist at Scailyte. She specializes in immunology, infectious diseases, and immuno-oncology.
Scailyte, the company she joined, developed an Artificial Intelligence driven platform that supports discovery of complex disease patterns from single-cell data. They’re at the forefront of advancing precision medicine through AI and multiomics analysis.
Find them at https://scailyte.com.
If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.
The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.